CymaBay Therapeutics (CBAY)
NASDAQ:CBAY
Holding CBAY?
Track your performance easily

CymaBay Therapeutics (CBAY) Financial Statements

1,568 Followers

CymaBay Therapeutics Financial Overview

CymaBay Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.991; its P/E ratio is -32.75; CymaBay Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 57.00K-$ 31.02M--
Gross Profit$ 57.00K-$ 31.02M--
EBIT$ -36.82M$ -29.04M$ 3.81M$ -24.38M$ -23.48M
EBITDA$ -39.23M$ -30.92M$ 2.03M$ -25.49M$ -23.89M
Net Income Common Stockholders$ -41.90M$ -33.88M$ -808.00K$ -28.78M$ -26.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 394.25M$ 438.78M$ 213.84M$ 236.37M$ 135.49M
Total Assets$ 434.69M$ 451.05M$ 226.65M$ 244.59M$ 141.85M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 30.00K
Net Debt$ -394.25M$ -438.78M$ -213.84M$ -236.37M$ -135.46M
Total Liabilities$ 142.43M$ 124.86M$ 118.24M$ 141.13M$ 105.70M
Stockholders Equity$ 292.26M$ 326.19M$ 108.45M$ 104.22M$ 36.15M
Cash Flow-
Free Cash Flow$ -27.56M$ -26.14M$ -25.51M$ 6.24M$ -18.77M
Operating Cash Flow$ -27.38M$ -26.14M$ -25.44M$ 6.43M$ -18.76M
Investing Cash Flow$ -42.11M$ 15.46M$ 719.00K$ -60.64M$ 8.36M
Financing Cash Flow$ 2.73M$ 248.92M$ 1.05M$ 93.07M-
Currency in USD

CymaBay Therapeutics Earnings and Revenue History

CymaBay Therapeutics Debt to Assets

CymaBay Therapeutics Cash Flow

CymaBay Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis